Acute respiratory distress syndrome: Shifting the emphasis from treatment to prevention

Michelle Ng Gong, B. Taylor Thompson

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Purpose of review Although results from clinical trials have advanced the treatment of acute respiratory distress syndrome (ARDS), mortality remains high. More recently, focus has shifted from treatment of ARDS to early identification and prevention in at-risk populations. Recent findings There have been 30 published and registered clinical trials with either the primary or secondary goal of reducing ARDS. Summary With this change in paradigm, come additional challenges and consideration in study design that depends not only on the intervention but also whether the intervention aims for a primary, secondary, or tertiary prevention of ARDS that targets a patient population for universal, selective, or indicated prevention. These epidemiologic concepts of prevention in public health also apply to ARDS and are relevant to the study population to target, the timing of the intervention relative to critical illness, the study design and outcomes to measure in an ARDS prevention study. This shift in focus is reflected by the new National Heart Lung Blood Institute Prevention and Early Treatment of Acute Lung Injury network, and signifies an overall movement away from reacting to and supporting acute organ failure after it is established to early detection and prevention in acute critical illness wherever and whenever it may occur.

Original languageEnglish (US)
Pages (from-to)21-37
Number of pages17
JournalCurrent Opinion in Critical Care
Volume22
Issue number1
DOIs
StatePublished - 2016

Fingerprint

Adult Respiratory Distress Syndrome
Critical Illness
Therapeutics
Tertiary Prevention
Clinical Trials
National Heart, Lung, and Blood Institute (U.S.)
Acute Lung Injury
Health Services Needs and Demand
Primary Prevention
Secondary Prevention
Public Health
Outcome Assessment (Health Care)
Mortality
Population

Keywords

  • Acute respiratory distress syndrome
  • Clinical trials
  • Prevention

ASJC Scopus subject areas

  • Critical Care and Intensive Care Medicine

Cite this

Acute respiratory distress syndrome : Shifting the emphasis from treatment to prevention. / Gong, Michelle Ng; Thompson, B. Taylor.

In: Current Opinion in Critical Care, Vol. 22, No. 1, 2016, p. 21-37.

Research output: Contribution to journalArticle

@article{0ff13bf8896d4e97976bd2c4c8dbfde2,
title = "Acute respiratory distress syndrome: Shifting the emphasis from treatment to prevention",
abstract = "Purpose of review Although results from clinical trials have advanced the treatment of acute respiratory distress syndrome (ARDS), mortality remains high. More recently, focus has shifted from treatment of ARDS to early identification and prevention in at-risk populations. Recent findings There have been 30 published and registered clinical trials with either the primary or secondary goal of reducing ARDS. Summary With this change in paradigm, come additional challenges and consideration in study design that depends not only on the intervention but also whether the intervention aims for a primary, secondary, or tertiary prevention of ARDS that targets a patient population for universal, selective, or indicated prevention. These epidemiologic concepts of prevention in public health also apply to ARDS and are relevant to the study population to target, the timing of the intervention relative to critical illness, the study design and outcomes to measure in an ARDS prevention study. This shift in focus is reflected by the new National Heart Lung Blood Institute Prevention and Early Treatment of Acute Lung Injury network, and signifies an overall movement away from reacting to and supporting acute organ failure after it is established to early detection and prevention in acute critical illness wherever and whenever it may occur.",
keywords = "Acute respiratory distress syndrome, Clinical trials, Prevention",
author = "Gong, {Michelle Ng} and Thompson, {B. Taylor}",
year = "2016",
doi = "10.1097/MCC.0000000000000275",
language = "English (US)",
volume = "22",
pages = "21--37",
journal = "Current Opinion in Critical Care",
issn = "1070-5295",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Acute respiratory distress syndrome

T2 - Shifting the emphasis from treatment to prevention

AU - Gong, Michelle Ng

AU - Thompson, B. Taylor

PY - 2016

Y1 - 2016

N2 - Purpose of review Although results from clinical trials have advanced the treatment of acute respiratory distress syndrome (ARDS), mortality remains high. More recently, focus has shifted from treatment of ARDS to early identification and prevention in at-risk populations. Recent findings There have been 30 published and registered clinical trials with either the primary or secondary goal of reducing ARDS. Summary With this change in paradigm, come additional challenges and consideration in study design that depends not only on the intervention but also whether the intervention aims for a primary, secondary, or tertiary prevention of ARDS that targets a patient population for universal, selective, or indicated prevention. These epidemiologic concepts of prevention in public health also apply to ARDS and are relevant to the study population to target, the timing of the intervention relative to critical illness, the study design and outcomes to measure in an ARDS prevention study. This shift in focus is reflected by the new National Heart Lung Blood Institute Prevention and Early Treatment of Acute Lung Injury network, and signifies an overall movement away from reacting to and supporting acute organ failure after it is established to early detection and prevention in acute critical illness wherever and whenever it may occur.

AB - Purpose of review Although results from clinical trials have advanced the treatment of acute respiratory distress syndrome (ARDS), mortality remains high. More recently, focus has shifted from treatment of ARDS to early identification and prevention in at-risk populations. Recent findings There have been 30 published and registered clinical trials with either the primary or secondary goal of reducing ARDS. Summary With this change in paradigm, come additional challenges and consideration in study design that depends not only on the intervention but also whether the intervention aims for a primary, secondary, or tertiary prevention of ARDS that targets a patient population for universal, selective, or indicated prevention. These epidemiologic concepts of prevention in public health also apply to ARDS and are relevant to the study population to target, the timing of the intervention relative to critical illness, the study design and outcomes to measure in an ARDS prevention study. This shift in focus is reflected by the new National Heart Lung Blood Institute Prevention and Early Treatment of Acute Lung Injury network, and signifies an overall movement away from reacting to and supporting acute organ failure after it is established to early detection and prevention in acute critical illness wherever and whenever it may occur.

KW - Acute respiratory distress syndrome

KW - Clinical trials

KW - Prevention

UR - http://www.scopus.com/inward/record.url?scp=84952716208&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84952716208&partnerID=8YFLogxK

U2 - 10.1097/MCC.0000000000000275

DO - 10.1097/MCC.0000000000000275

M3 - Article

C2 - 26645554

AN - SCOPUS:84952716208

VL - 22

SP - 21

EP - 37

JO - Current Opinion in Critical Care

JF - Current Opinion in Critical Care

SN - 1070-5295

IS - 1

ER -